| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Patrice Courvalin | |
| Trevor Winstanley | |||
| P2860 | cites work | Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital | Q46653069 |
| Identification of glycopeptide-resistant enterococci by VITEK 2 system and conventional and real-time polymerase chain reaction | Q46718840 | ||
| Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. | Q46895499 | ||
| Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains | Q46988565 | ||
| High tech. High touch. John Naisbett's world view | Q47449400 | ||
| Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae | Q47586573 | ||
| Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals | Q47971500 | ||
| Prevalence of enterococcal high-level aminoglycoside resistance in Japan. Comparative detection by three methods | Q48334761 | ||
| Lecture to the London Mathematical Society on 20 February 1947. 1986. | Q48507725 | ||
| Variables processing in expert system building: application to the aetiological diagnosis of infantile meningitis | Q48651569 | ||
| Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. | Q50611240 | ||
| Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. | Q51082163 | ||
| Automated systems in the identification and determination of methicillin resistance among coagulase negative staphylococci. | Q51186993 | ||
| Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program. | Q51187843 | ||
| Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods. | Q51700680 | ||
| Artificial intelligence techniques for monitoring dangerous infections. | Q51953656 | ||
| Correlation study of two routine bacteriology systems with previously characterised strains. | Q52040371 | ||
| An intelligent rapid odour recognition model in discrimination of Helicobacter pylori and other gastroesophageal isolates in vitro. | Q52067584 | ||
| Evaluation of an expert system linked to a rapid antibiotic susceptibility testing system for the detection of beta-lactam resistance phenotypes. | Q52305858 | ||
| A probabilistic rule-based expert system. | Q52391210 | ||
| Validation of the medical expert system PNEUMON-IA. | Q52409343 | ||
| MYCIN and NEOMYCIN: two approaches to generating explanations in rule-based expert systems. | Q52471425 | ||
| Minimycin: a miniature rule-based system. | Q52666956 | ||
| Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. | Q53602663 | ||
| Medical diagnosis, diagnostic spaces, and fuzzy systems. | Q53604732 | ||
| Phenotypic detection of beta-lactamase-mediated resistance to oxyimino-cephalosporins in Enterobacteriaceae: evaluation of the Mastascan Elite Expert System. | Q53853945 | ||
| Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. | Q53941913 | ||
| [Interpretative reading of the non-fermenting gram-negative bacilli antibiogram]. | Q53966956 | ||
| Instrumentation in antimicrobial susceptibility testing. | Q54004119 | ||
| [False resistance to imipenem in gram negative bacilli with and automatized system] | Q54020053 | ||
| Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae | Q38478132 | ||
| Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods | Q38551271 | ||
| Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system | Q38561310 | ||
| Evaluation of the GIDEON expert computer program for the diagnosis of imported febrile illnesses | Q38916135 | ||
| Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins | Q39399105 | ||
| Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. | Q39455190 | ||
| Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci | Q39463064 | ||
| Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital | Q39465236 | ||
| Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms | Q39466691 | ||
| Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa | Q39475887 | ||
| Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance | Q39760823 | ||
| Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms | Q39762100 | ||
| Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa | Q39848627 | ||
| Comparison and evaluation of Osiris and Sirscan 2000 antimicrobial susceptibility systems in the clinical microbiology laboratory | Q39848713 | ||
| Performance of an agar dilution method and a Vitek 2 card for detection of inducible clindamycin resistance in Staphylococcus spp. | Q39899618 | ||
| Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. | Q40087945 | ||
| Evaluation of MicroScan rapid panels for detection of high-level aminoglycoside resistance in enterococci. | Q40190065 | ||
| Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp. | Q40201290 | ||
| Evaluation of the newly modified AutoMicrobic system gram-positive susceptibility-MIC card for detection of methicillin-resistant Staphylococcus aureus. | Q40205332 | ||
| Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards | Q40212219 | ||
| Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis | Q40214234 | ||
| Comparison of the new MicroScan Pos MIC Type 6 panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species | Q40222511 | ||
| Evaluation of the BD PHOENIX automated microbiology system for detection of methicillin resistance in coagulase-negative staphylococci | Q40282607 | ||
| Improvement in user performance following development and routine use of an expert system. | Q40963803 | ||
| The HELP system and its application to infection control | Q41151198 | ||
| Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci | Q41483827 | ||
| ALERT: a clinical case simulator program for serious, communicable, and rare diseases. | Q41496552 | ||
| Antimicrobial susceptibility testing: general principles and contemporary practices | Q41752677 | ||
| Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods | Q41809654 | ||
| Performance of MicroScan WalkAway and Vitek 2 for detection of oxacillin resistance in a set of methicillin-resistant Staphylococcus aureus isolates with diverse genetic backgrounds | Q41810327 | ||
| Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests | Q41878926 | ||
| BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin | Q41881612 | ||
| Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases | Q41939169 | ||
| Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection | Q42054277 | ||
| Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels | Q42127782 | ||
| Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. | Q42130010 | ||
| Redesigning an infection control application to support an enterprise model. | Q42156936 | ||
| Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae | Q42413051 | ||
| Evaluation of moxalactam with the BD phoenix system for detection of methicillin resistance in coagulase-negative staphylococci | Q42432104 | ||
| Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci | Q42637617 | ||
| Evaluation and updating of the Osiris expert system for identification of Escherichia coli beta-lactam resistance phenotypes | Q42722087 | ||
| Ability of the modified Vitek card to detect coagulase-negative staphylococcal with mecA and Oxacillin-resistant phenotypes | Q42725354 | ||
| Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate | Q42725452 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Evaluation of a new molecular system for simultaneous identification of four Enterococcus species and their glycopeptide resistance genotypes | Q42863710 | ||
| vanC gene-related intrinsic teicoplanin resistance detected in Enterococcus casseliflavus and E. gallinarum strains by the BD phoenix automated microbiology system | Q42942796 | ||
| Shall we report the carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii strains detected by BD Phoenix system? | Q43022070 | ||
| Detection of vancomycin-intermediate Staphylococcus aureus with the updated Trek-Sensititre System and the MicroScan System. Comparison with results from the conventional Etest and CLSI standardized MIC methods | Q43062273 | ||
| Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus | Q43097113 | ||
| Comparison of the BD Phoenix system with the cefoxitin disk diffusion test for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci. | Q43097193 | ||
| Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates. | Q43149111 | ||
| Unreliable extended-spectrum beta-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates. | Q43179783 | ||
| Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci | Q43186672 | ||
| Cefepime MIC breakpoint resettlement in gram-negative bacteria | Q43215469 | ||
| False susceptibility to cefotetan reported by MicroScan for DHA-type AmpC beta-lactamase-producing Klebsiella pneumoniae | Q79852822 | ||
| [Evaluation of Vitek 2 performance for identifying extended spectrum beta-lactamases in Enterobacteriaceae "other than Escherichia coli, Proteus mirabilis and Klebsiella spp"] | Q80020078 | ||
| VITEK 2 failure in screening Hafnia alvei inducible beta-lactam resistance | Q81356819 | ||
| Screening of antibiotics resistance to Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii by an advanced expert system | Q82044826 | ||
| Susceptibility testing and resistance phenotypes detection in bacterial pathogens using the VITEK 2 System | Q83109947 | ||
| Evaluation of the capability of the VITEK 2 system to detect extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes | Q83341760 | ||
| Can we rely on one laboratory test in detection of extended-spectrum beta-lactamases among Enterobacteriaceae? An evaluation of the Vitek 2 system and comparison with four other detection methods in Kuwait | Q83753929 | ||
| [Comparative assessment of the Vitek 2 and Phoenix systems for detection of extended-spectrum beta-lactamases] | Q83926781 | ||
| Medintel: decision support for general practitioners: a case study | Q84542902 | ||
| [Automatic decision support system in prognostication, diagnosis, treatment and prophylaxis of chronic prostatitis] | Q84709776 | ||
| Infusing clinical decision support interventions into electronic health records | Q84797467 | ||
| Probability, Logic and Medical Diagnosis | Q94543612 | ||
| Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae | Q24550605 | ||
| beta-Lactamases in laboratory and clinical resistance | Q24669605 | ||
| Variation in the abilities of automated, commercial, and reference methods to detect methicillin-resistant (heteroresistant) Staphylococcus aureus | Q30451578 | ||
| Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates. | Q33200631 | ||
| Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway | Q33418763 | ||
| Computer-assisted diagnostic decision support: history, challenges, and possible paths forward | Q33492815 | ||
| Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates | Q33592967 | ||
| Quality of antimicrobial susceptibility testing in the UK: a Pseudomonas aeruginosa survey revisited | Q33647957 | ||
| Comparison of eight methods to detect vancomycin resistance in enterococci | Q33657965 | ||
| Failure of quality control measures to prevent reporting of false resistance to imipenem, resulting in a pseudo-outbreak of imipenem-resistant Pseudomonas aeruginosa | Q33658003 | ||
| Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides | Q33661713 | ||
| Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci | Q33679146 | ||
| Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreona | Q33682354 | ||
| Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci | Q33715948 | ||
| Development of an expert system for bacterial identification: study of a prototype for identifying beta-galactosidase positive enterobacteria | Q33744857 | ||
| Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues | Q33769534 | ||
| Multicenter comparison of the ISO standard 20776-1 and the serial 2-fold dilution procedures to dilute hydrophilic and hydrophobic antifungal agents for susceptibility testing | Q33827020 | ||
| Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers | Q33920474 | ||
| Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test | Q33963773 | ||
| Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. | Q33965292 | ||
| Evaluation of the Sirscan automated zone reader in a clinical microbiology laboratory | Q33966650 | ||
| Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci | Q33967332 | ||
| Limitations of vitek GPS-418 cards in exact detection of vancomycin-resistant enterococci with the vanB genotype | Q33967641 | ||
| Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system | Q33969789 | ||
| Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus | Q33970805 | ||
| Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital | Q33972569 | ||
| Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
| Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphyloc | Q33973659 | ||
| Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates | Q38475591 | ||
| Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories. | Q54034069 | ||
| Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique. | Q54034510 | ||
| Comparison of the Vitek GPS-TB card with disk diffusion testing for predicting the susceptibility of enterococci to vancomycin. | Q54090249 | ||
| [Sensitivity to selected beta-lactam antibiotics of clinical strains of Escherichia coli and Klebsiella pneumoniae] | Q54098029 | ||
| Accuracy of cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway System. | Q54098838 | ||
| Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam. | Q54185969 | ||
| Detection of ampicillin resistance in Enterococcus spp. by disk diffusion and two commercial automated systems. | Q54228007 | ||
| [Comparison of ATB STREP, AMS-Vitek GPS-TA, and disk diffusion for the detection of a high level of aminoglycoside resistance in Enterococcus spp.] | Q54243031 | ||
| Laboratory detection of extended-spectrum beta-lactamase by an automated system. | Q54411449 | ||
| [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis]. | Q54420239 | ||
| Susceptibility testing of methicillin-resistant Staphylococcus aureus with three commercial microdilution systems. | Q54423115 | ||
| Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases. | Q54429502 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli isolated in the Al-Amiri Hospital in 2003 and compared with isolates from the Farwania hospital outbreak in 1994-96 in Kuwait. | Q54439037 | ||
| Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli. | Q54457021 | ||
| Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species. | Q54467020 | ||
| Acceptable performance of VITEK 2 system to detect extended-spectrum beta-lactamases in clinical isolates of Escherichia coli: a comparative study of phenotypic commercial methods and NCCLS guidelines. | Q54489799 | ||
| Evaluation of VITEK 2 for analysis of Enterobacteriaceae using the Advanced Expert System (AES) versus interpretive susceptibility guidelines used at Dynacare Kasper Medical Laboratories, Edmonton, Alberta | Q54515548 | ||
| Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit. | Q54572082 | ||
| Evaluation of diagnostic tests for infectious diseases: general principles | Q56829038 | ||
| Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative | Q56880333 | ||
| Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos | Q58387239 | ||
| Species identification and detection of oxacillin resistance in coagulase-negative Staphylococcus blood isolates from neutropenic patients | Q67841321 | ||
| [An expert system for differentiation of viral meningitis] | Q67971584 | ||
| Detection of extended-spectrum beta-lactamases by the rapid ATB E technique. Value of the API V2.1.1 expert system | Q68006381 | ||
| [Use of an expert system as a tool to carry out urinary cyto-bacteriologic tests] | Q68019343 | ||
| [Interpretative reading and quality control of an antibiotic sensitivity test using an expert system. Application to the API ATB system and Enterobacteriaceae] | Q69760910 | ||
| [Evaluation of ceftazidime treatment in septicemia expert systems] | Q70064915 | ||
| [An expert system as an aid to the validation of results of the antibiogram. Feasibility study based on the example of Staphylococcus aureus] | Q70198094 | ||
| Evaluation of modified MicroScan screening tests for high-level aminoglycoside resistance in Enterococcus faecalis | Q70595166 | ||
| Species identification and determination of high-level aminoglycoside resistance among enterococci. Comparison study of sterile body fluid isolates, 1985-1991 | Q70646490 | ||
| Treatment failure due to extended spectrum beta-lactamase | Q71119710 | ||
| Detection of vancomycin resistance in enterococci by the Vitek AMS system | Q72571799 | ||
| [Detection of the phenotypes of resistance of enterobacteriaceae to aminoglycosides with ATB Plus Expert System] | Q72588237 | ||
| [Laboratory-evaluation of antimicrobial susceptibility testings to detect vancomycin-resistant enterococci] | Q73309159 | ||
| Detection of oxacillin-resistance in Staphylococcus aureus by MicroScan MIC panels in comparison to four other methods | Q73332577 | ||
| Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases | Q73366783 | ||
| Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli | Q73484720 | ||
| Comparison of phenotypic methods to identify enterococci intrinsically resistant to vancomycin (VanC VRE) | Q73516082 | ||
| Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes | Q74071459 | ||
| Comparison of the MICs of cefepime for extended-spectrum beta-lactamase-producing and non-extended-spectrum beta-lactamase-producing strains of Enterobacter cloacae | Q74138082 | ||
| Clonal dissemination of vancomycin-resistant Enterococci and comparison of susceptibility testing methods | Q74532186 | ||
| Detection of methicillin resistance in coagulase-negative staphylococci initially reported as methicillin susceptible using automated methods | Q74532196 | ||
| Multicenter evaluation of an automated system using selected bacteria that harbor challenging and clinically relevant mechanisms of resistance to antibiotics | Q77195517 | ||
| Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime | Q77583674 | ||
| The influence of an expert system for test ordering and interpretation on laboratory investigations | Q78077757 | ||
| Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility te | Q79775229 | ||
| Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens | Q79802854 | ||
| Evaluation of the vitek 2 AST-P559 card for detection of oxacillin resistance in Staphylococcus aureus. | Q43235530 | ||
| Detection of carbapenem resistance in clinical mucoid Pseudomonas aeruginosa isolates | Q43239631 | ||
| Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium | Q43248345 | ||
| Evaluation of the VITEK 2 advanced expert system for reporting piperacillin susceptibility in Klebsiella spp. | Q43253667 | ||
| A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae | Q43412718 | ||
| Performance of the VITEK2 system for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates. | Q43597775 | ||
| Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test | Q43627836 | ||
| Evaluation of phenotypic methods for methicillin resistance characterization in coagulase-negative staphylococci (CNS). | Q43652534 | ||
| Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae | Q43665731 | ||
| Artificial-intelligence-based hospital-acquired infection control. | Q43688500 | ||
| Evaluation of the OSIRIS video reader system for disk diffusion susceptibility test reading | Q43725609 | ||
| Oxoid aura system as a semi-automated, standard antimicrobial susceptibility test method | Q43749808 | ||
| Evaluation of an automated system for the identification and antimicrobial susceptibility testing of enterococci. | Q43750716 | ||
| Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases. | Q43785356 | ||
| Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes | Q43819618 | ||
| Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime | Q43820678 | ||
| Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests | Q43869460 | ||
| Bacterio-expert: an integrated system for assisting in the validation of antibiotic sensitivity tests. Retrospective application in 4053 Staphylococcus | Q43886351 | ||
| Comparison of different detection methods for methicillin resistance in Staphylococcus aureus | Q43952966 | ||
| Oxacillin susceptibility testing of coagulase-negative staphylococci using the disk diffusion method and the Vitek GPS-105 card | Q43990655 | ||
| A study of the usage of a decision-support system for infective endocarditis | Q44044224 | ||
| Remote access to an expert system for infectious diseases | Q44109857 | ||
| Detection of extended spectrum beta-lactamases in the routine clinical microbiology laboratory | Q44110769 | ||
| Broad spectrum beta-lactamases and the API ATB 244 system: the need for detection | Q44172419 | ||
| Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan | Q44429032 | ||
| Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan | Q44481918 | ||
| Accuracy of four agar diffusion methods and the Vitek 2 automated system for the detection of the methicillin resistance in coagulase negative staphylococci | Q44755036 | ||
| Digital documentation in the microbiology laboratory using the BACMED 4i system - an analyser of inhibition zones and equivalence of MIC with the BEES expert system | Q44775421 | ||
| Identification of methicillin-resistant isolates of Staphylococcus aureus and coagulase-negative staphylococci responsible for bloodstream infections with the Phoenix system | Q44828621 | ||
| Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection | Q44901126 | ||
| High incidence of extended-spectrum beta-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method | Q44904504 | ||
| Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study | Q44999201 | ||
| Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria | Q45096410 | ||
| Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK 2 system, and comparison with two NCCLS reference methods | Q45178326 | ||
| Evaluation of the Vitek 2 system for identification and antimicrobial susceptibility testing of Staphylococcus spp. | Q45243576 | ||
| Erroneous reporting of vancomycin susceptibility for Staphylococcus spp. by Vitek software version 2.01. | Q45921348 | ||
| [Molecular characterization of Pseudomonas aeruginosa isolates in Cantabria, Spain, producing VIM-2 metallo-beta-lactamase]. | Q46028407 | ||
| Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa | Q46049797 | ||
| Evaluation of methods for studying susceptibility to oxacillin and penicillin in 60 Staphylococcus lugdunensis isolates | Q46078545 | ||
| Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis | Q46100026 | ||
| Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance | Q46167675 | ||
| Difficulties in detection and identification of Enterococcus faecium with low-level inducible resistance to vancomycin, during a hospital outbreak | Q46323901 | ||
| A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria. | Q46371215 | ||
| Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam | Q46431263 | ||
| Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections | Q46431265 | ||
| Correlation of agar dilution and VITEK2 system for detection of resistance to macrolides, lincosamides and pristinamycin among Staphylococcus aureus and Staphylococcus epidermidis: association with genotypes | Q46594123 | ||
| Evaluation of the Vitek card GPS105 and VTK-RO7.01 software for detection of oxacillin resistance in clinically relevant coagulase-negative staphylococci | Q33973739 | ||
| Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains | Q33973951 | ||
| Evaluation of a latex agglutination test (MRSA-Screen) for detection of oxacillin resistance in coagulase-negative Staphylococci | Q33974108 | ||
| Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q33983667 | ||
| Laboratory detection of extended-spectrum beta-lactamases (ESBLs)--the need for a reliable, reproducible method. | Q34023919 | ||
| Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae | Q34046522 | ||
| Comparison of ATB staph, rapid ATB staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA | Q34072778 | ||
| Evaluation of screening and commercial methods for detection of methicillin resistance in coagulase-negative staphylococci | Q34073530 | ||
| Evaluation of the BIOMIC video reader system for determining interpretive categories of isolates on the basis of disk diffusion susceptibility results. | Q34073744 | ||
| Rapid detection of methicillin resistance in coagulase-negative Staphylococci with the VITEK 2 system. | Q34196138 | ||
| Detection of methicillin resistance in primary blood culture isolates of coagulase-negative staphylococci by PCR, slide agglutination, disk diffusion, and a commercial method | Q34196886 | ||
| Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. | Q34201311 | ||
| Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium | Q34429494 | ||
| Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates | Q34749318 | ||
| Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method | Q34974437 | ||
| Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species | Q35027121 | ||
| Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa | Q35155857 | ||
| In vitro detection of enterococcal vancomycin resistance | Q35275414 | ||
| Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility | Q35281765 | ||
| In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis | Q35350299 | ||
| Detection of methicillin and mupirocin resistance in Staphylococcus aureus isolates using conventional and molecular methods: a descriptive study from a burns unit with high prevalence of MRSA. | Q35586410 | ||
| Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2). | Q35784407 | ||
| Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing | Q35793289 | ||
| Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing | Q35913952 | ||
| Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy | Q35922116 | ||
| Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. | Q36279116 | ||
| Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms | Q36313244 | ||
| Diagnosing community-acquired pneumonia with a Bayesian network | Q36441263 | ||
| Use of CLIPS for representation and inference in a clinical event monitor | Q36443991 | ||
| An expert system for culture-based infection control surveillance | Q36470870 | ||
| Use of computerized decision support systems to improve antibiotic prescribing | Q36505523 | ||
| Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci | Q36528805 | ||
| Evaluation of Vitek GPS-SA card for testing of oxacillin against borderline-susceptible staphylococci that lack mec. | Q36534397 | ||
| ??? | Q62495274 | ||
| Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. | Q36535597 | ||
| Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. | Q36541997 | ||
| Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa | Q36545818 | ||
| Comparative evaluation of four systems for determining susceptibility of gram-positive organisms | Q36771753 | ||
| Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin | Q36845387 | ||
| A decision support system for microbiology quality control | Q36889412 | ||
| Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints | Q37043635 | ||
| Evaluation of differential inoculum disk diffusion method and Vitek GPS-SA card for detection of oxacillin-resistant staphylococci | Q37071693 | ||
| Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases | Q37073128 | ||
| Imipenem stability in a predried susceptibility panel. | Q37094416 | ||
| Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis | Q37114177 | ||
| Detection of vancomycin resistance in Enterococcus species | Q37122804 | ||
| Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus | Q37124817 | ||
| Detection of intrinsically resistant (heteroresistant) Staphylococcus aureus with the Sceptor and AutoMicrobic systems. | Q37136499 | ||
| Evaluation of MicroScan MIC panels for detection of oxacillin-resistant staphylococci | Q37148549 | ||
| Laboratory detection of high-level aminoglycoside-aminocyclitol resistance in Enterococcus spp. | Q37157770 | ||
| Evaluation of MicroScan rapid gram-positive panels for detection of oxacillin-resistant staphylococci | Q37165689 | ||
| Evaluation of the AutoMicrobic system Gram-Positive Susceptibility-MIC card for detection of oxacillin-resistant coagulase-negative staphylococci | Q37203933 | ||
| Detection of methicillin-resistant Staphylococcus epidermidis | Q37209201 | ||
| Modification of the Sceptor system for rapid detection of methicillin-resistant staphylococci | Q37209806 | ||
| Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis | Q37211894 | ||
| Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels | Q37230830 | ||
| False resistance to imipenem with a microdilution susceptibility testing system | Q37233527 | ||
| Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis | Q37242595 | ||
| Evaluation of the Vitek GPS-TA card for laboratory detection of high-level gentamicin and streptomycin resistance in enterococci | Q37247230 | ||
| Detection of methicillin-resistant Staphylococcus aureus by microdilution and disk elution susceptibility systems | Q37273490 | ||
| Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. | Q37309903 | ||
| Decision support systems for antibiotic prescribing. | Q37319011 | ||
| Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia | Q37333683 | ||
| Clinical decision support systems to prevent and treat pressure ulcers and under-nutrition in nursing homes | Q37547833 | ||
| Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy | Q37624439 | ||
| Embedding expert systems in laboratory information systems | Q37972199 | ||
| Implementing GermWatcher, an enterprise infection control application. | Q38442065 | ||
| An Expert PArasite IdentificatiON (EPAION) system with multimedia support | Q38455893 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | expert system | Q184609 |
| P304 | page(s) | 515-556 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | Expert systems in clinical microbiology | |
| P478 | volume | 24 |
| Q47330235 | Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015-16. |
| Q40362864 | Carbapenem Resistance in Non-Fermentative Bacterial Species and in Enterobacteriaceae Isolates from Hospitalized Patients in Different Health-Care Settings. |
| Q91829846 | Carbapenem-Resistant Klebsiella pneumoniae: Microbiology Key Points for Clinical Practice |
| Q46958203 | Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study. |
| Q34297646 | Clinical microbiology informatics. |
| Q45739887 | Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates |
| Q33820956 | Current and emerging techniques for antibiotic susceptibility tests |
| Q34336969 | Detection of New Delhi metallo-β-lactamase (encoded by blaNDM-1) in Acinetobacter schindleri during routine surveillance |
| Q34472033 | Detection of bacterial 16S rRNA and identification of four clinically important bacteria by real-time PCR. |
| Q54346349 | Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. |
| Q35669092 | Evaluation of the PREVI® Isola automated seeder system compared to reference manual inoculation for antibiotic susceptibility testing by the disk diffusion method |
| Q36261351 | High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain |
| Q57175319 | Identification and Antibiotic-Susceptibility Profiling of Infectious Bacterial Agents: A Review of Current and Future Trends |
| Q40987237 | Identification of Emerging Human Mastitis Pathogens by MALDI-TOF and Assessment of Their Antibiotic Resistance Patterns. |
| Q48132316 | Incidence and Determinants of Health Care-Associated Blood Stream Infection at a Neonatal Intensive Care Unit in Ujjain, India: A Prospective Cohort Study. |
| Q39147849 | Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably? |
| Q35163990 | Investigating specific bacterial resistance to AMPs by using a magainin I-resistant Escherichia coli model |
| Q34728453 | Low prevalence of methicillin resistant Staphylococcus aureus as determined by an automated identification system in two private hospitals in Nairobi, Kenya: a cross sectional study |
| Q88924840 | Methicillin-resistant Staphylococcus aureus |
| Q35094264 | Multiresistant strains are as susceptible to photodynamic inactivation as their naïve counterparts: protoporphyrin IX-mediated photoinactivation reveals differences between methicillin-resistant and methicillin-sensitive Staphylococcus aureus strain |
| Q33833985 | Quality of water and antibiotic resistance of Escherichia coli from water sources of hilly tribal villages with and without integrated watershed management-a one year prospective study |
| Q35788824 | Rapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy |
| Q40672387 | The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations. |
| Q41080071 | Validation of antibiotic susceptibility testing guidelines in a routine clinical microbiology laboratory exemplifies general key challenges in setting clinical breakpoints |
Search more.